SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-015936
Filing Date
2023-05-09
Accepted
2023-05-09 16:05:18
Documents
15
Period of Report
2023-05-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44466
2 ex16-1.htm EX-16.1 7092
3 ex99-1.htm EX-99.1 14537
4 ex16-1_001.jpg GRAPHIC 10011
  Complete submission text file 0001493152-23-015936.txt   263230

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vvos-20230509.xsd EX-101.SCH 3218
6 XBRL LABEL FILE vvos-20230509_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE vvos-20230509_pre.xml EX-101.PRE 22353
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3724
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 23901879
SIC: 3841 Surgical & Medical Instruments & Apparatus